Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1437-160X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data ; day:2 ; month:9 ; year:2020 ; pages:1-10
Rheumatology international ; (2.9.2020), 1-10
- Urheber
-
Pappas, Dimitrios A.
Litman, Heather J.
Lesperance, Tamara
Kricorian, Greg
Karis, Elaine
Rebello, Sabrina
Hua, Winnie
Accortt, Neil A.
Stryker, Scott
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00296-020-04667-5
- URN
-
urn:nbn:de:101:1-2020102319145424119423
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pappas, Dimitrios A.
- Litman, Heather J.
- Lesperance, Tamara
- Kricorian, Greg
- Karis, Elaine
- Rebello, Sabrina
- Hua, Winnie
- Accortt, Neil A.
- Stryker, Scott
- SpringerLink (Online service)
Ähnliche Objekte (12)
Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan® Databases
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Long-term remission and biologic persistence rates: 12-year real-world data
Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study
Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies
Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis
Living with Ulcerative Colitis in Japan: Biologic Persistence and Health-Care Resource Use
Efficacy of levothyroxine monotherapy in achieving clinical euthyroidism and its impact on weight loss in women with hypothyroidism and obesity
Perspectives on Categorical Persistence
Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry
Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic
Afghan perspectives on achieving durable peace
Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan® Databases
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Long-term remission and biologic persistence rates: 12-year real-world data
Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study
Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies
Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis
Living with Ulcerative Colitis in Japan: Biologic Persistence and Health-Care Resource Use
Efficacy of levothyroxine monotherapy in achieving clinical euthyroidism and its impact on weight loss in women with hypothyroidism and obesity
Perspectives on Categorical Persistence
Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry
Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic
Afghan perspectives on achieving durable peace
Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan® Databases
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Long-term remission and biologic persistence rates: 12-year real-world data
Drug Persistence of Biologic Treatments in Psoriasis: A Swedish National Population Study
Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies
Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis
Living with Ulcerative Colitis in Japan: Biologic Persistence and Health-Care Resource Use
Efficacy of levothyroxine monotherapy in achieving clinical euthyroidism and its impact on weight loss in women with hypothyroidism and obesity
Perspectives on Categorical Persistence
Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry
Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic